Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026)
Nuwellis' (NUWE) quarterly Total Non-Current Liabilities came in at $3.9 million in Q1 2026, up 31.09% YoY from $3.0 million in Q1 2025, and up 26.82% on a QoQ basis from $3.1 million in Q4 2025.
Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
Nuwellis (NUWE) has 11 years of Total Non-Current Liabilities data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 31.09% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 31.09% YoY) and the FY2025 annual result came in at $3.1 million, up 8.13% from the prior year.
- Total Non-Current Liabilities rose to $3.9 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $8.2 million in Q2 2025 to a low of $2.9 million in Q4 2024.
- A 5-year average of $4.2 million and a median of $4.3 million in 2022 frame the typical range for Total Non-Current Liabilities.
- The widest YoY moves for Total Non-Current Liabilities: up 83.51% in 2025, down 37.68% in 2025.
- Tracing NUWE's Total Non-Current Liabilities over 5 years: stood at $5.4 million in 2022, then sank by 31.79% to $3.7 million in 2023, then slipped by 22.87% to $2.9 million in 2024, then climbed by 8.13% to $3.1 million in 2025, then advanced by 26.82% to $3.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $3.9 million (Q1 2026), $3.1 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Nuwellis | 204,804.59 | -3.72 Mn | 1.50 Mn | 4.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.21 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 4.82 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 30, 2022 | 4.42 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 4.47 Mn |
| Sep 30, 2021 | 3.83 Mn |